Archive for April 2022
Specialized Pro-Resolving Mediators (SPMs) as Potential Covid-19 Therapeutic
April 21, 2022 Introduction Our last Perspective described how the timing of the type 1 interferon (IFN) response is a critical early point in determining whether infection with SARS-CoV2 will lead to severe disease or not. IFN activity later in infection, when disease has already developed, is apparently ineffective, and is instead detrimental. Indeed, an…
Read MoreJapanese Encephalitis Virus: Ongoing Public Health Threat
April 7, 2022 Introduction Japanese encephalitis virus (JEV) is the leading cause of vaccine-preventable encephalitis. JEV is a flavivirus (genus Flavivirus, family Flaviviridae) and shares a close genetic and antigenic relationship with West Nile virus, St. Louis encephalitis virus, and Murray Valley encephalitis virus (1). Most people infected with JE do not have symptoms or…
Read MoreGLOBAL VIRUS NETWORK AND ABBOTT LAUNCH PANDEMIC DEFENSE POSTDOCTORAL FELLOWSHIP PROGRAM
The partnership is training the next generation of virologists to combat future pandemic threats, with a focus on pathogen discovery in developing nations Baltimore, Maryland, USA, April 6, 2022 – The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats, and Abbott, the global healthcare company, announce…
Read More